Previous Article | Next Article ![]()
Journal of Virology, November 2001, p. 10906-10911, Vol. 75, No. 22
Laboratory of Structural Biology, National
Institute of Environmental Health Sciences, National Institutes of
Health, Research Triangle Park, North Carolina
277091; Department of Microbiology and
Immunology, Joan and Sanford I. Weill Medical College of Cornell
University, New York, New York 100212;
Progenics Pharmaceuticals Inc., Tarrytown, New York
105913; and Institute for Applied
Microbiology, University of Agriculture and Forestry, 1190 Vienna,
Austria4
Received 9 May 2001/Accepted 13 August 2001
Matrix-assisted laser desorption ionization mass spectrometry
(MALDI-MS), in combination with proteolytic protection assays, has been
used to identify the functional epitope on human immunodeficiency virus envelope glycoprotein gp41 for the broadly neutralizing anti-gp41 human monoclonal antibody 2F5. In this protection assay-based procedure, a soluble gp140 protein with a stabilizing intermolecular disulfide bond between the gp120 and gp41 subunits (SOS gp140) was affinity bound to immobilized 2F5 under physiological
conditions. A combination of proteolytic enzymatic cleavages was
then performed to remove unprotected residues. Residues of SOS gp140
protected by their binding to 2F5 were then identified based on their
molecular weights as determined by direct MALDI-MS of the immobilized
antibody beads. The epitope, NEQELLELDKWASLWN, determined by
this MALDI-MS protection assay approach consists of 16 amino acid
residues near the C terminus of gp41. It is significantly
longer than the ELDKWA core epitope previously determined for 2F5
by peptide enzyme-linked immunosorbent assay. This new
knowledge of the structure of the 2F5 epitope may facilitate the design
of vaccine antigens intended to induce antibodies with the breadth and
potency of action of the 2F5 monoclonal antibody.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.22.10906-10911.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Fine Definition of the Epitope on the gp41 Glycoprotein of Human
Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal
Antibody 2F5
*
Corresponding author. Mailing address for Leesa J. Deterding: Laboratory of Structural Biology, National Institute of
Environmental Health Sciences, National Institutes of Health, P.O.
Box 12233, Research Triangle Park, NC 27709. Phone: (919) 541-3009. Fax: (919) 541-0220. E-mail: deterding{at}niehs.nih.gov.
Present address for Carol E. Parker: Dept. of Biochemistry and
Biophysics, CB7260, University of North Carolina School of Medicine,
Chapel Hill, NC 27599. Phone: (919) 966-9989. Fax: (919) 966-2852. E-mail: Carol_Parker{at}med.unc.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|